Menu
GeneBe

PGM2L1

phosphoglucomutase 2 like 1

Basic information

Region (hg38): 11:74330315-74398433

Links

ENSG00000165434NCBI:283209OMIM:611610HGNC:20898Uniprot:Q6PCE3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalitiesARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Dermatologic; Musculoskeletal; Neurologic33979636

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PGM2L1 gene.

  • not provided (25 variants)
  • Inborn genetic diseases (12 variants)
  • Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PGM2L1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
10
clinvar
1
clinvar
2
clinvar
13
nonsense
2
clinvar
2
start loss
0
frameshift
4
clinvar
4
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
16
clinvar
16
Total 6 0 11 1 19

Variants in PGM2L1

This is a list of pathogenic ClinVar variants found in the PGM2L1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-74336638-A-G Benign (May 14, 2021)1285855
11-74336824-A-AT Benign (May 26, 2021)1232198
11-74338524-A-G Benign (May 04, 2021)1238575
11-74338579-C-T Inborn genetic diseases Uncertain significance (Nov 29, 2023)3211856
11-74338763-G-A Benign (May 14, 2021)1287924
11-74342502-C-T Benign (May 04, 2021)1238287
11-74342507-C-T Inborn genetic diseases Uncertain significance (Aug 16, 2021)3211855
11-74342508-G-A Inborn genetic diseases Uncertain significance (Dec 07, 2023)3211854
11-74342528-G-A PGM2L1-related disorder Likely benign (Jan 20, 2022)3034165
11-74342543-GGA-G Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities Pathogenic (Jan 11, 2023)2443753
11-74342575-C-A Inborn genetic diseases Uncertain significance (Nov 08, 2021)2360802
11-74343130-A-G Benign (May 17, 2021)1221198
11-74343301-G-T Benign (May 14, 2021)1236874
11-74343325-A-G Inborn genetic diseases Uncertain significance (Jan 19, 2022)2230965
11-74343332-C-A Inborn genetic diseases Pathogenic (May 10, 2022)2283908
11-74343353-C-A Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities Pathogenic (Nov 10, 2022)1008756
11-74345482-CCTT-C Uncertain significance (Aug 01, 2023)2578663
11-74345571-AT-A Neurodevelopmental disorder with hypotonia, dysmorphic facies, and skin abnormalities Pathogenic (Nov 10, 2022)1060646
11-74345645-AAC-A Pathogenic (Jul 18, 2022)2144201
11-74346602-T-C Benign (May 14, 2021)1294901
11-74346742-G-A Inborn genetic diseases Uncertain significance (May 18, 2023)2548644
11-74346767-A-C Inborn genetic diseases Uncertain significance (Oct 06, 2021)2372478
11-74346886-C-T Benign (May 14, 2021)1241016
11-74347203-T-C Inborn genetic diseases Uncertain significance (Jan 06, 2023)2474233
11-74351303-ACACTTTTTAT-A Benign (May 26, 2021)1268532

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PGM2L1protein_codingprotein_codingENST00000298198 1468156
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.02590.9741257120361257480.000143
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.242143280.6520.00001644088
Missense in Polyphen84141.610.593191701
Synonymous1.14981130.8640.000005371169
Loss of Function3.72931.50.2850.00000150411

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003040.000301
Ashkenazi Jewish0.00009930.0000992
East Asian0.00005440.0000544
Finnish0.00009270.0000924
European (Non-Finnish)0.0001960.000193
Middle Eastern0.00005440.0000544
South Asian0.0001040.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Glucose 1,6-bisphosphate synthase using 1,3- bisphosphoglycerate as a phosphate donor and a series of 1- phosphate sugars as acceptors, including glucose 1-phosphate, mannose 1-phosphate, ribose 1-phosphate and deoxyribose 1- phosphate. 5 or 6-phosphosugars are bad substrates, with the exception of glucose 6-phosphate. Also synthesizes ribose 1,5- bisphosphate. Has only low phosphopentomutase and phosphoglucomutase activities. {ECO:0000269|PubMed:17804405, ECO:0000269|PubMed:18927083}.;
Pathway
Starch and sucrose metabolism - Homo sapiens (human);Glycogen synthetase deficiency;Glycogenosis, Type III. Cori disease, Debrancher glycogenosis;Mucopolysaccharidosis VI. Sly syndrome;Sucrase-isomaltase deficiency;Glycogenosis, Type IV. Amylopectinosis, Anderson disease;Glycogenosis, Type VI. Hers disease;Starch and Sucrose Metabolism;Metabolism of carbohydrates;Metabolism;Glycolysis;Galactose catabolism;Glucose metabolism;Glycogen breakdown (glycogenolysis);Glycogen synthesis;Glycogen metabolism (Consensus)

Recessive Scores

pRec
0.204

Intolerance Scores

loftool
0.707
rvis_EVS
0.51
rvis_percentile_EVS
80.2

Haploinsufficiency Scores

pHI
0.445
hipred
Y
hipred_score
0.639
ghis
0.511

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.152

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pgm2l1
Phenotype

Gene ontology

Biological process
glycogen biosynthetic process;glycogen catabolic process;galactose catabolic process;canonical glycolysis
Cellular component
cytosol
Molecular function
phosphoglucomutase activity;metal ion binding;glucose-1,6-bisphosphate synthase activity